LOMBARD MEDICAL, INC.
4 Trident Park
Didcot
Oxfordshire OX 11 7HJ
United Kingdom
April 10, 2014
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Attention: Amanda Ravitz
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Lombard Medical, Inc. |
| Registration Statement on Form F-1 |
| File No. 333-194461 |
| Request for Acceleration |
Ladies and Gentlemen:
Lombard Medical, Inc. (the “Registrant”) herebywithdraws its previously filed request to the Commission to accelerate, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Lombard Medical, Inc. (the “Registrant”) to accelerate of the effective date of its Registration Statement on Form F-1 (File No. 333-194461), as amended (the “Registration Statement”), so that it may become effective at 5:00 p.m. EST, on April 10, 2014.
Please contact Kristian Wiggert of Covington & Burling LLP, special U.S. counsel to the Company, at +44 20 7067 2280 or kwiggert@cov.com or Brian Rosenzweig of this firm at 212-841-1108 or brozenzweig@cov.com, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.
| Very truly yours, | ||
| LOMBARD MEDICAL, INC. | ||
| By: | /s/ IAN ARDILL | |
| Name: | Ian Ardill | |
| Title: | Chief Financial Officer | |
